Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Ringshausen, FC; Baumann, I; de Roux, A; Dettmer, S; Diel, R; Eichinger, M; Ewig, S; Flick, H; Hanitsch, L; Hillmann, T; Koczulla, R; Köhler, M; Koitschev, A; Kugler, C; Nüsslein, T; Ott, SR; Pink, I; Pletz, M; Rohde, G; Sedlacek, L; Slevogt, H; Sommerwerck, U; Sutharsan, S; von Weihe, S; Welte, T; Wilken, M; Rademacher, J; Mertsch, P.
Management of adult bronchiectasis Consensus-based Guidelines for the German Respiratory Society (DGP) e.V.(AWMF registration number 020-030)
PNEUMOLOGIE. 2024; 78(11): 833-899.
Doi: 10.1055/a-2311-9450
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Flick Holger
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Bronchiectasis is an etiologically heterogeneous, chronic, and often progressive respiratory disease characterized by irreversible bronchial dilation. It is frequently associated with significant symptom burden, multiple complications, and reduced quality of life. For several years, there has been a marked global increase in the prevalence of bronchiectasis, which is linked to a substantial economic burden on healthcare systems. This consensus-based guideline is the first German-language guideline addressing the management of bronchiectasis in adults. The guideline emphasizes the importance of thoracic imaging using CT for diagnosis and differentiation of bronchiectasis and highlights the significance of etiology in determining treatment approaches. Both non-drug and drug treatments are comprehensively covered. Non-pharmacological measures include smoking cessation, physiotherapy, physical training, rehabilitation, non-invasive ventilation, thoracic surgery, and lung transplantation. Pharmacological treatments focus on the long-term use of mucolytics, bronchodilators, anti-inflammatory medications, and antibiotics. Additionally, the guideline covers the challenges and strategies for managing upper airway involvement, comorbidities, and exacerbations, as well as socio-medical aspects and disability rights. The importance of patient education and self-management is also emphasized. Finally, the guideline addresses special life stages such as transition, family planning, pregnancy and parenthood, and palliative care. The aim is to ensure comprehensive, consensus-based, and patient-centered care, taking into account individual risks and needs.